<?xml version="1.0" encoding="UTF-8"?>
<p>No adverse events related to SYT occurred in our pilot study. In a future protocol, all adverse events are to be recorded regardless of the possible association to herbal treatment. Herbal treatment is to be discontinued if either the attending oncologist or the trial investigator believes that the patient may be at risk of harm, including disability, hospitalization, or death.</p>
